Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Cancers|March 29, 2023
Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell CancerSharia Hernandez, Prajnan Das, Emma B Holliday, et al.
Journal of the National Cancer Institute|December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyRichard M Goldberg, Richard Adams, Marc Buyse, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2022
Microbiome Dynamics During Chemoradiation Therapy for Anal CancerDaniel Lin, Molly B El Alam, Joseph Abi Jaoude, et al.
Cancer|June 25, 2025
Consensus guideline for the management of colorectal cancer with peritoneal metastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.
The Lancet. Oncology|February 23, 2017
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 studyVan K Morris, Mohamed E Salem, Halla Nimeiri, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal MetastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus GuidelinesSimron Singh, Emily K Bergsland, Cynthia M Card, et al.
Plos One|April 27, 2018
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studiesMala Pande, Aron Joon, Abenaa M Brewster, et al.
JCO Precision Oncology|March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working GroupLakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Lancet (London, England)|June 18, 2023
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, et al.
Pageof 32